# Relpax

NDC: 0049-2330
Generic name: eletriptan hydrobromide
Labeler / Manufacturer: ROERIG
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: TABLET, FILM COATED
Routes: ORAL
Marketing started: 20021226
Marketing ended: 20260531
FDA application: NDA021016

## Active ingredients

- ELETRIPTAN HYDROBROMIDE: 20 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"0049-2330"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0049-2330
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=85745375-fcb6-4edc-b6db-a77b4a5f3e8c